Complete excision and management of large hyaline-vascular pelvic Castleman's disease with coexisting cholecystolithiasis: A rare case report

被引：0

作者：

Jeo, Wifanto Saditya ^{[1
]}

Haryono, Samuel ^{[2
]}

Gultom, Fajar Lamhot ^{[3
]}

Chaspuri, Dismas Adiasa ^{[4
]}

Nikijuluw, Rachmat Christian ^{[5
]}

Yoladifa, Safira Farah ^{[1
]}

机构：

[1] Univ Indonesia, Dr Cipto Mangunkusumo Gen Hosp, Fac Med, Div Digest Surg,Dept Surg, Jakarta, Indonesia

[2] Dharmais Canc Hosp, Dept Oncol Surg, Jakarta, Indonesia

[3] MRCCC Siloam Hosp, Dept Anat Pathol, Jakarta, Indonesia

[4] MRCCC Siloam Hosp, Dept Surg, Jakarta, Indonesia

[5] MRCCC Siloam Hosp, Dept Oncol Surg, Jakarta, Indonesia

来源：

INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS | 2025年 / 128卷

关键词：

Case report; Unicentric; Castleman's disease; Retroperitoneal; Pelvic mass resection; Lymphadenopathy;

D O I：

10.1016/j.ijscr.2025.111019

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Introduction: Castleman's disease (CD) refers to scarce lymphovascular hyperplasia categorized as unicentric (UCD) or multicentric (MCD). Retroperitoneal UCD is uncommon (6.7 %) and frequently grows undetected, making diagnosis challenging. The hypervascular nature of hyaline-vascular variant and the average larger size of UCD may result in complete resection difficulty. We present a case of large pelvic UCD completely resected without previous prophylactic procedures or massive intraoperative bleeding with coexisting cholecystolithiasis, which follows the SCARE 2023 guidelines. Case presentation: A 45-year-old male was accidentally observed with pelvic mass suppressing ureter and right internal iliac artery in preoperative MRI for cholecystolithiasis and cholecystitis. Epigastric pain, vomiting, and jaundice due to the inflamed gallbladder had resolved before mass removal. Biopsy and immunohistochemistry (IHC) tests confirmed the hyaline-vascular CD. Complete resection per laparotomy was done due to lesion adherence and identified a 7x5x2.5 cm solid mass with cystic degeneration suppressing the ureter. After five months, the patient fully recovered with no symptoms. Discussion: Asymptomatic mass presented as lymphadenopathy on imaging should suggest CD. A prompt lymph node biopsy followed by a pre- or postoperative IHC test is important in diagnosing CD. Total pelvic mass excision with rectum preservation is feasible for larger (>5 cm) hypervascularized masses without remarkable bleeding and promotes recovery without adjunctive treatments. Conclusion: Complete excision per laparotomy is accessible for the uncommon large pelvic retroperitoneal UCD-suppressing ureter.

引用

页数：4

共 20 条

[1] Castleman B., Iverson L., Mendez V.P., Localized mediastinal lymph-node hyperplasia resembling thymoma, Cancer, 9, pp. 822-830, (1956)
[2] Muhammad T., Alkheder A., Mazloum A., Almooay A., Naziha L., Shaheen M., Unicentric Castleman disease: a case report of an atypical presentation and successful management, Int. J. Surg. Case Rep., 118, (2024)
[3] Zhao Q., Zhang X., Yang X., Huang S., Castleman's disease in the pelvic retroperitoneum: a case report, Exp. Ther. Med., 24, (2022)
[4] Molacek J., Treska V., Skalicky T., Vodicka J., Ferda J., Ferdova E., Et al., Unicentric form of Castleman's disease, pitfalls of diagnosis and surgical treatment, Front. Oncol., 13, (2023)
[5] Sohrabi C., Mathew G., Maria N., Kerwan A., Franchi T., Agha R.A., The SCARE 2023 guideline: updating consensus surgical case REport (SCARE) guidelines, Int. J. Surg., 109, pp. 1136-1140, (2023)
[6] Jiang Z.-J., Feng S., Liu G., Chen M., Sun J.-J., Castleman's disease combined with choledocholithiasis: a case report and review of literature, International Journal of Clinical Experimental Pathology, 11, pp. 5491-5496, (2018)
[7] Dhakre V.W., Nagral S., Nanavati A.J., Castleman's disease in carcinoma gall bladder, BMJ Case Rep., (2016)
[8] Van Rhee F., Oksenhendler E., Srkalovic G., Voorhees P., Lim M., Dispenzieri A., Et al., International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease, Blood Adv., 4, pp. 6039-6050, (2020)
[9] Sumiyoshi R., Koga T., Kawakami A., Biomarkers and signaling pathways implicated in the pathogenesis of idiopathic multicentric Castleman disease/thrombocytopenia, anasarca, fever, Reticulin fibrosis, renal insufficiency, and Organomegaly (TAFRO) syndrome, Biomedicines, 12, (2024)
[10] Xiao P., Wang Q., Dong Z., Su J., Chen Y., Fan W., Ten-year anemia as initial manifestation of Castleman disease in the abdominal cavity: a case report, Open Life Sciences, 19, (2024)

← 1 2 →